{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:58:51Z","timestamp":1785279531245,"version":"3.55.0"},"reference-count":57,"publisher":"American Chemical Society (ACS)","issue":"16","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-1-I2M-054"],"award-info":[{"award-number":["2021-1-I2M-054"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epilepsy is one of the most common and life-threatening neurological diseases, and the GABAARs are important therapeutic targets for epilepsy. Herein, a series of novel 2,7-disubstituted isoindolin-1-one derivatives were designed and synthesized, and extensive structure\u2013activity relationships led to a number of highly potent PAMs of GABAARs with EC50 values at 10\u20137\u201310\u20138 M level and Emax value of 5\u201315-fold. In particular, Cpd48 exhibited strong in vitro potentiation effects toward both synaptic and extra-synaptic GABAARs, and produced highly potent in vivo efficacies in mouse seizure models, including sc-PTZ (ED50 = 8.20 mg\/kg), MES (ED50 = 2.68 mg\/kg), and pilocarpine-induced SE model. Furthermore, Cpd48 displayed a high selectivity for GABAARs over other key CNS ion channels (&amp;gt;100-fold). It also possessed desirable plasma PK properties and BBB penetration ability. Altogether, Cpd48 could serve as a unique lead compound for further developing new antiseizure agents with differentiated pharmacological profiles.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c01161","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:15:26Z","timestamp":1754889326000},"page":"17538-17564","source":"Crossref","is-referenced-by-count":2,"title":["Discovery of\nNovel Isoindolin-1-one Derivatives as\nGABAA Receptors Positive Allosteric Modulators with Antiepileptic\nEfficacy"],"prefix":"10.1021","volume":"68","author":[{"given":"Meizhen","family":"Tian","sequence":"first","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leqi","family":"Fan","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-2034","authenticated-orcid":true,"given":"Jinping","family":"Hu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Yu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-0887","authenticated-orcid":true,"given":"Bailing","family":"Xu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College , , ,","place":["Beijing, China, 100050"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"2026072812084303000_cit1","unstructured":"WHO.\n          . Epilepsy. 2024. Available\nfrom: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy (accessed March 6, 2025)."},{"issue":"5","key":"2026072812084303000_cit2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation\nof the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"2026072812084303000_cit3","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat.\nRev. Dis. Primers"},{"issue":"9","key":"2026072812084303000_cit4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41573-024-00981-w","article-title":"New Epilepsy\nTherapies in Development","volume":"23","author":"Klein","year":"2024","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"4","key":"2026072812084303000_cit5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11910-016-0640-y","article-title":"Practice Update:\nReview of Anticonvulsant Therapy","volume":"16","author":"Chong","year":"2016","journal-title":"Curr. Neurol.\nNeurosci. Rep."},{"issue":"10","key":"2026072812084303000_cit6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for anti-epileptic\ndrug discovery and development","volume":"12","author":"Lo\u0308scher","year":"2013","journal-title":"Nat. Rev. Drug\nDiscovery"},{"issue":"3","key":"2026072812084303000_cit7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug Resistance in\nEpilepsy: Clinical Impact, Potential Mechanisms, and New Innovative\nTreatment Options","volume":"72","author":"Lo\u0308scher","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"2026072812084303000_cit8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union\nof Pharmacology. LXX. Subtypes\nof gamma-aminobutyric acid(A) receptors: classification on the basis\nof subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"2026072812084303000_cit9","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1021\/acs.jmedchem.9b01312","article-title":"Subtype Selective\n\u03b3-Aminobutyric Acid Type A Receptor (GABAAR) Modulators\nActing at the Benzodiazepine Binding Site: An Update","volume":"63","author":"Maramai","year":"2020","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026072812084303000_cit10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/dneu.22536","article-title":"GABA type A receptor trafficking\nand the architecture\nof synaptic inhibition","volume":"78","author":"Lorenz-Guertin","year":"2018","journal-title":"Dev. Neurobiol."},{"issue":"4","key":"2026072812084303000_cit11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tips.2009.12.005","article-title":"Binding, activation\nand modulation of Cys-loop receptors","volume":"31","author":"Miller","year":"2010","journal-title":"Trends\nPharmacol. Sci."},{"issue":"48","key":"2026072812084303000_cit12","doi-asserted-by":"publisher","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation\nof GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"7712","key":"2026072812084303000_cit13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41586-018-0255-3","article-title":"Structure of a human\nsynaptic GABAA receptor","volume":"559","author":"Zhu","year":"2018","journal-title":"Nature"},{"issue":"7740","key":"2026072812084303000_cit14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-018-0833-4","article-title":"Cryo-EM structure of the human \u03b11\u03b23\u03b32\nGABAA receptor in a lipid bilayer","volume":"565","author":"Laverty","year":"2019","journal-title":"Nature"},{"issue":"7740","key":"2026072812084303000_cit15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","article-title":"GABAA receptor signalling\nmechanisms revealed by structural pharmacology","volume":"565","author":"Masiulis","year":"2019","journal-title":"Nature"},{"issue":"7824","key":"2026072812084303000_cit16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2654-5","article-title":"Shared\nstructural mechanisms of general anaesthetics and benzodiazepines","volume":"585","author":"Kim","year":"2020","journal-title":"Nature"},{"issue":"7981","key":"2026072812084303000_cit17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-023-06556-w","article-title":"Cryo-EM structures\nreveal native\nGABAA receptor assemblies and pharmacology","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"1","key":"2026072812084303000_cit18","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1038\/s41467-023-40800-1","article-title":"Structural\ninsights into opposing\nactions of neurosteroids on GABAA receptors","volume":"14","author":"Legesse","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"2026072812084303000_cit19","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1038\/s41467-022-32212-4","article-title":"Structural and dynamic\nmechanisms of GABAA receptor modulators with opposing activities","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"issue":"8050","key":"2026072812084303000_cit20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41586-024-08454-1","article-title":"Resolving native\nGABAA receptor structures from the\nhuman brain","volume":"638","author":"Zhou","year":"2025","journal-title":"Nature"},{"issue":"4","key":"2026072812084303000_cit21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International\nUnion of Basic and Clinical Pharmacology.\nCVI: GABAA Receptor Subtype- and Function-selective Ligands:\nKey Issues in Translation to Humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol.\nRev."},{"key":"2026072812084303000_cit22","doi-asserted-by":"publisher","first-page":"108035","DOI":"10.1016\/j.pharmthera.2021.108035","article-title":"GABAkines\u2013Advances\nin the discovery, development, and commercialization of positive allosteric\nmodulators of GABAA receptors","volume":"234","author":"Cerne","year":"2022","journal-title":"Pharmacol.\nTher."},{"issue":"1","key":"2026072812084303000_cit23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40265-019-01250-6","article-title":"Cenobamate:\nFirst Approval","volume":"80","author":"Keam","year":"2020","journal-title":"Drugs"},{"issue":"8","key":"2026072812084303000_cit24","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/medicina59081389","article-title":"Cenobamate\n(YKP3089) and Drug-Resistant Epilepsy: A\nReview of the Literature","volume":"59","author":"Rissardo","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"2026072812084303000_cit25","doi-asserted-by":"publisher","first-page":"173117","DOI":"10.1016\/j.ejphar.2020.173117","article-title":"Positive\nallosteric modulation of GABAA receptors by a novel antiepileptic\ndrug cenobamate","volume":"879","author":"Sharma","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"2026072812084303000_cit26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/diseases9030052","article-title":"Treating Postpartum Depression: What\nDo We Know about Brexanolone?","volume":"9","author":"Ali","year":"2021","journal-title":"Diseases"},{"issue":"1","key":"2026072812084303000_cit27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1021\/jm960021x","article-title":"Synthesis\nand in vitro activity of 3\u03b2-substituted-3\u03b1-hydroxypregnan-20-ones:\nallosteric modulators of the GABAA receptor","volume":"40","author":"Hogenkamp","year":"1997","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026072812084303000_cit28","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/14737175.2021.1904895","article-title":"Ganaxolone treatment for epilepsy\npatients: from pharmacology to place in therapy","volume":"21","author":"Lattanzi","year":"2021","journal-title":"Expert Rev. Neurother."},{"issue":"8","key":"2026072812084303000_cit29","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1021\/acs.jmedchem.5b00032","article-title":"Neuroactive Steroids. 1. Positive\nAllosteric Modulators of the (\u03b3-Aminobutyric Acid)A Receptor:\nStructure-Activity Relationships of Heterocyclic Substitution at C-21","volume":"58","author":"Martinez Botella","year":"2015","journal-title":"J. Med. Chem."},{"issue":"18","key":"2026072812084303000_cit30","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1021\/acs.jmedchem.7b00846","article-title":"Neuroactive Steroids. 2. 3\u03b1-Hydroxy-3\u03b2-methyl-21-(4-cyano-1H-pyrazol-1\u2032-yl)-19-nor-5\u03b2-pregnan-20-one\n(SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive\nAllosteric Modulator of the (\u03b3-Aminobutyric Acid)A Receptor","volume":"60","author":"Martinez Botella","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026072812084303000_cit31","doi-asserted-by":"publisher","first-page":"108333","DOI":"10.1016\/j.neuropharm.2020.108333","article-title":"Preclinical characterization\nof zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator","volume":"181","author":"Althaus","year":"2020","journal-title":"Neuropharmacology"},{"issue":"2","key":"2026072812084303000_cit32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/jm00308a035","article-title":"Antiinflammatory\n2-aryl-1,3-indandiones","volume":"11","author":"Lombardino","year":"1968","journal-title":"J. Med. Chem."},{"issue":"4","key":"2026072812084303000_cit33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/00304948.2019.1621085","article-title":"Reinvestigation of Atipamezole Synthesis\nand Preparation of New Analogs","volume":"51","author":"Karrabi","year":"2019","journal-title":"Org. Prep. Proced.\nInt."},{"key":"2026072812084303000_cit34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1570178614666170221143302","article-title":"Phthalimidine\nsynthesis via the direct condensation between phthalide\nand primary amine in the presence of catalytic amount of InCl3","volume":"14","author":"Takahashi","year":"2017","journal-title":"Lett. Org. Chem."},{"issue":"13","key":"2026072812084303000_cit35","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.1021\/acs.jmedchem.0c00233","article-title":"Discovery of 3-Pyridyl\nIsoindolin-1-one\nDerivatives as Potent, Selective, and Orally Active Aldosterone Synthase\n(CYP11B2) Inhibitors","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"issue":"7897","key":"2026072812084303000_cit36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41586-022-04402-z","article-title":"Mechanisms of Inhibition\nand Activation of Extrasynaptic \u03b1\u03b2 GABAA Receptors","volume":"602","author":"Kasaragod","year":"2022","journal-title":"Nature"},{"issue":"6","key":"2026072812084303000_cit37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.410380609","article-title":"Experimental Status Epilepticus Alters\nGamma-Aminobutyric\nAcid Type A Receptor Function in CA1 Pyramidal Neurons","volume":"38","author":"Kapur","year":"1995","journal-title":"Ann. Neurol."},{"issue":"10","key":"2026072812084303000_cit38","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-Specific\nTrafficking of GABAA Receptors during Status Epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"issue":"13","key":"2026072812084303000_cit39","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/hmg\/ddh146","article-title":"GABRD Encoding a Protein for Extra-\nor Peri-synaptic\nGABAA Receptors Is a Susceptibility Locus for Generalized Epilepsies","volume":"13","author":"Dibbens","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"2026072812084303000_cit40","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/jnen\/nlz085","article-title":"Alterations in GABAA Receptor\nSubunit Expression in the Amygdala and Entorhinal Cortex in Human\nTemporal Lobe Epilepsy","volume":"78","author":"Stefanits","year":"2019","journal-title":"J. Neuropathol. Exp.\nNeurol."},{"issue":"8","key":"2026072812084303000_cit41","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1093\/brain\/awy171","article-title":"De Novo Variants in GABRA2 and GABRA5 Alter Receptor Function and Contribute to\nEarly-Onset Epilepsy","volume":"141","author":"Butler","year":"2018","journal-title":"Brain"},{"issue":"5","key":"2026072812084303000_cit42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review\nof current animal models of seizures and epilepsy used in the discovery\nand development of new antiepileptic drugs","volume":"20","author":"Lo\u0308scher","year":"2011","journal-title":"Seizure"},{"key":"2026072812084303000_cit43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1684\/epd.2012.0532","article-title":"Animal models\nof drug-resistant epilepsy","volume":"14","author":"Potschka","year":"2012","journal-title":"Epileptic Disord."},{"issue":"3","key":"2026072812084303000_cit44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41401-023-01195-3","article-title":"Schisandrin B, a dual positive allosteric modulator of GABAA and glycine receptors, alleviates seizures in multiple mouse models","volume":"45","author":"Wu","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"2026072812084303000_cit45","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/j.1528-1167.2010.02593.x","article-title":"Anticonvulsant\nand proconvulsant actions of 2-deoxy-D-glucose","volume":"51","author":"Gasior","year":"2010","journal-title":"Epilepsia"},{"issue":"3","key":"2026072812084303000_cit46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification\nof seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"2026072812084303000_cit47","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1007\/s00213-014-3494-5","article-title":"Pharmacological\nprofile of a 17\u03b2-heteroaryl-substituted\nneuroactive steroid","volume":"231","author":"Hogenkamp","year":"2014","journal-title":"Psychopharmacology"},{"key":"2026072812084303000_cit48","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1213\/01.ane.0000261519.04083.3e","article-title":"Increased gamma-aminobutyric\nacid levels in mouse brain\ninduce loss of righting reflex, but not immobility, in response to\nnoxious stimulation","volume":"104","author":"Katayama","year":"2007","journal-title":"Anesth. Analg."},{"key":"2026072812084303000_cit49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1124\/jpet.118.252155","article-title":"Intravenously Administered\nGanaxolone\nBlocks Diazepam-Resistant Lithium-Pilocarpine-Induced Status Epilepticus\nin Rats: Comparison with Allopregnanolone","volume":"368","author":"Saporito","year":"2019","journal-title":"J.\nPharmacol. Exp. Ther."},{"key":"2026072812084303000_cit50","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bja.2022.06.041","article-title":"Hypoxia-triggered O-GlcNAcylation in the brain drives the glutamate-glutamine\ncycle and reduces sensitivity to sevoflurane in mice","volume":"129","author":"He","year":"2022","journal-title":"Br. J. Anaesth."},{"key":"2026072812084303000_cit51","doi-asserted-by":"publisher","first-page":"176494","DOI":"10.1016\/j.ejphar.2024.176494","article-title":"The role\nof astrocytic \u03b3-aminobutyric\nacid in the action of inhalational anesthetics","volume":"970","author":"Won","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"2026072812084303000_cit52","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide:\nA New Approach for Rapid, Accurate Docking and Scoring. 1. Method\nand Assessment of Docking Accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med.\nChem."},{"key":"2026072812084303000_cit53","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/(SICI)1096-987X(20000130)21:2&lt;132::AID-JCC5&gt;3.0.CO;2-P","article-title":"Fast, Efficient\nGeneration of High-Quality Atomic Charges. AM1-BCC Model: I. Method","volume":"21","author":"Jakalian","year":"2000","journal-title":"J. Comput. Chem."},{"key":"2026072812084303000_cit54","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"FF19SB: Amino-Acid-Specific Protein Backbone Parameters\nTrained against Quantum Mechanics Energy Surfaces in Solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theory Comput."},{"key":"2026072812084303000_cit55","doi-asserted-by":"publisher","first-page":"12582","DOI":"10.1039\/D1CP01169C","article-title":"The Development\nof an Amber-Compatible Organosilane Force Field for Drug-Like Small\nMolecules","volume":"23","author":"Dong","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"2026072812084303000_cit56","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for Processing and Analysis\nof Molecular Dynamics Trajectory Data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem.\nTheory Comput."},{"key":"2026072812084303000_cit57","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","article-title":"Lessons Learned in Empirical Scoring\nwith Smina from the CSAR 2011 Benchmarking Exercise","volume":"53","author":"Koes","year":"2013","journal-title":"J. Chem. Inf. Model."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c01161","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/16\/17538\/66296397\/acs.jmedchem.5c01161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/16\/17538\/66296397\/acs.jmedchem.5c01161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:12:12Z","timestamp":1785276732000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/16\/17538\/5234874\/Discovery-of-Novel-Isoindolin-1-one-Derivatives-as"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":57,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8,11]]},"published-print":{"date-parts":[[2025,8,28]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01161","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}